Condensyl is a dietary supplement in tablet form designed to restore the oxy-redox balance and the cell viability.
Each cell must maintain a perfect oxy-redox equilibrium so as to ensure the normal operation of all metabolic processes. It is a dynamic balance which needs continuous adjustments in response to the variable oxidative metabolic and environmental load. The inability of cells to adapt, because of constitutional, environmental and / or nutritional factors, commonly results in an oxidative excess.
Indirect antioxidant activity
The assumption of common antioxidants (direct antioxidants) can promote a reductive shift in metabolism in proportion to the dose but is unable, by definition, to maintain the balance that the cells need. They will always be too weak to correct the imbalance or too strong so as to cause an imbalance in the opposite direction.
The opposite imbalance induced by antioxidants, reductive stress, is just as harmful as oxidative stress and can seriously affect the most delicate functions, first of all reproductive.
Substances in Condensyl: N-acetylcysteine or L-cystine, Opuntia fruit extract (betalains, quercetine), niacin, zinc chelate, vitamin E, riboflavin, vitamin B6, folic acid, vitamin B12
The antioxidant effect of Condensyl™ is the maximum attainable by the cell by its own. It is by definition greater than that obtainable with direct antioxidants that will act (often in excess) only the specific biochemical reactions involving the specific substances administered and thus affecting only some of the innumerable aspects of oxidative damage.
Conversely, Condensyl™ contains only nutrient substrates devoid of any pharmacological action so, at times when such substances are not necessary (eg. consumption of a richer meal), they will have no effect. One speaks in these cases of self-limiting action that is a prerequisite for the lack of phenomena of overdosage and of excessive effects. Similarly there are no particular limitations on the duration of use.
Indications to support with Condensyl
Condensyl™ is recommended for all those who have high levels of circulating homocysteine and / or high risk of cardiovascular and neurodegenerative disease.
However, the remarkable efficacy of antioxidant activation on the one hand and the respect for metabolic physiology on the other one make it the ideal support to fertility and to the health of the pregnancy and of the newborns. In fact, gametogenesis and embryogenesis are among those physiological functions requiring more than others a perfect metabolic balance.
On the world scene Condensyl™ and Procrelia™ are the first and currently only nutritional brands that are statistically superior to no treatment in improving pregnancy rates in couples resistant to Assisted Reproductive Technologies (ART) due to a male factor.
The published clinical studies included the most difficult cases, i.e. men with high level of sperm DNA fragmentation or nuclear decondensation, both predictive of impaired fertility, and being part of couples with a history of at least two ART failures. Treatment with Condensyl ™ significantly reduced both indices and the pregnancy occurred only from the patients who reported such improvements. The number and the percentage of pregnancies obtained were not only statistically superior to those obtained in untreated controls, but such as to be perhaps better than expected in couples without the serious risk factors of those included in the studies. It is a revolution that led Condensyl™ to the attention of the international scientific community. These are expected to be confirmed by many studies still underway.
55% of pregnancies with term labor occurred spontaneously, ie before the couple had time to undergo a new ART cycle.
Clinical studies carried out so far have focused on male infertility because it is the model in which it is easier to see and measure any effects. Given the similarity of the problems associated and the results already achieved by Procrelia™ it is expected a similar effectiveness even in female infertility.